These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18528705)

  • 1. Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.
    Silva SD; Cunha IW; Rangel AL; Jorge J; Zecchin KG; Agostini M; Kowalski LP; Coletta RD; Graner E
    Virchows Arch; 2008 Jul; 453(1):57-67. PubMed ID: 18528705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.
    da Silva SD; Cunha IW; Nishimoto IN; Soares FA; Carraro DM; Kowalski LP; Graner E
    Oral Oncol; 2009 Oct; 45(10):e134-9. PubMed ID: 19362044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
    Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
    Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
    Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
    Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage.
    Hague A; Eveson JW; MacFarlane M; Huntley S; Janghra N; Thavaraj S
    J Pathol; 2004 Oct; 204(2):175-82. PubMed ID: 15376256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
    Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
    J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
    Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
    Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.
    Lai KC; Chang KW; Liu CJ; Kao SY; Lee TC
    Mol Cancer Res; 2008 Sep; 6(9):1431-9. PubMed ID: 18819931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
    Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
    J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
    Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
    Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIP2A expression and localization in oral carcinoma and dysplasia.
    Katz J; Jakymiw A; Ducksworth MK; Stewart CM; Bhattacharyya I; Cha S; Chan EK
    Cancer Biol Ther; 2010 Oct; 10(7):694-9. PubMed ID: 21068540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
    Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
    Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.
    Shahrabi-Farahani S; Gallottini M; Martins F; Li E; Mudge DR; Nakayama H; Hida K; Panigrahy D; D'Amore PA; Bielenberg DR
    Am J Pathol; 2016 Apr; 186(4):1055-64. PubMed ID: 26877262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.